Видео ютуба по тегу Joshua Sabari

Meet Medical Oncologist Dr. Joshua Sabari
Meet Medical Oncologist Dr. Joshua Sabari
Challenges and Opportunities in Clinical Research with Narrow Populations Joshua Sabari, MD
Challenges and Opportunities in Clinical Research with Narrow Populations Joshua Sabari, MD
Dr. Joshua Sabari: Why Is It Important for You to Empower Patients?
Dr. Joshua Sabari: Why Is It Important for You to Empower Patients?
[STO Spotlight] Unedited Josh Sabari on PRO from the Beamion LUNG-1 trial
[STO Spotlight] Unedited Josh Sabari on PRO from the Beamion LUNG-1 trial
Changing the Treatment Landscape for Patients with NSCLC and EGFR Mutations
Changing the Treatment Landscape for Patients with NSCLC and EGFR Mutations
Lung Cancer ASCO 2024 Practice Changing Highlights - Discussion with Dr. Joshua Sabari
Lung Cancer ASCO 2024 Practice Changing Highlights - Discussion with Dr. Joshua Sabari
Dr. Sabari Discusses Role of Immunotherapy in SCLC
Dr. Sabari Discusses Role of Immunotherapy in SCLC
Medical Oncology Updates for Lung Cancer
Medical Oncology Updates for Lung Cancer
Dr Sabari on the FDA Approval of Amivantamab/Lazertinib in EGFR+ Advanced NSCLC
Dr Sabari on the FDA Approval of Amivantamab/Lazertinib in EGFR+ Advanced NSCLC
Dr. Sabari on Managing Immune-Related Adverse Events in Lung Cancer
Dr. Sabari on Managing Immune-Related Adverse Events in Lung Cancer
Dr. Sabari Discusses Immunotherapy Biomarkers in NSCLC
Dr. Sabari Discusses Immunotherapy Biomarkers in NSCLC
Annual Lung Cancer Awareness Program 2019
Annual Lung Cancer Awareness Program 2019
RET/MET/BRAF: initial treatment, acquired resistance, Q&A Joshua Sabari, MD Joshua Bauml, MD
RET/MET/BRAF: initial treatment, acquired resistance, Q&A Joshua Sabari, MD Joshua Bauml, MD
Understanding Non-Small Cell Lung Cancer: Types, Biomarkers, and Treatment Insights
Understanding Non-Small Cell Lung Cancer: Types, Biomarkers, and Treatment Insights
How important is NGS for biomarker testing in NSCLC?
How important is NGS for biomarker testing in NSCLC?
Dr Sabari on Barriers to Biomarker Testing in NSCLC
Dr Sabari on Barriers to Biomarker Testing in NSCLC
Dr. Sabari on Biomarkers of Response to Immunotherapy in Advanced NSCLC
Dr. Sabari on Biomarkers of Response to Immunotherapy in Advanced NSCLC
KRYSTAL-1: activity of adagrasib in KRASG12m NSCLC with untreated CNS metastases
KRYSTAL-1: activity of adagrasib in KRASG12m NSCLC with untreated CNS metastases
EGFR Mutation-Positive Non-Small Cell Lung Cancer — Proceedings from a Session Held During the 20...
EGFR Mutation-Positive Non-Small Cell Lung Cancer — Proceedings from a Session Held During the 20...
Dr. Sabari on Immunotherapy Updates in Small Cell Lung Cancer
Dr. Sabari on Immunotherapy Updates in Small Cell Lung Cancer